Hybrid polymeric matrices for oral modified release of Desvenlafaxine succinate tablets
Purpose: Desvenlafaxine succinate (DSV) is a water soluble anti-depressant drug, which is rapidly absorbed after oral administration exaggerating its side effects. The current work aimed to prepare controllable release DSV matrix to reduce DSV side effects related to its initial burst. Methods: Fift...
Main Authors: | Wael Samy, Ayman Elnoby, Hanan M. El-Gowelli, Nazik Elgindy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-07-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016416301104 |
Similar Items
-
Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
by: Gustavo Vaiano Carapeto, et al.
Published: (2023-05-01) -
Drug–drug interactions involving antidepressants: focus on desvenlafaxine
by: Low Y, et al.
Published: (2018-02-01) -
COMPARATIVE STUDIES ON SYNTHESIS AND STRUCTURE OF OLD AND NEW POLYMORPHS OF DESVENLAFAXINE - AN ANTIDEPRESSANT DRUG
by: Mahendra Khandpekar, et al.
Published: (2014-01-01) -
Periodontal status in chronic periodontitis depressed patients on desvenlafaxine: An observational study
by: Anu Bhatia, et al.
Published: (2018-01-01) -
Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery
by: Gui-Feng Tong, et al.
Published: (2017-09-01)